Page last updated: 2024-12-05
butylcaptax
Description
Butylcaptax, also known as N-tert-butyl-2-benzothiazyl sulfenamide, is a versatile rubber accelerator. It is a secondary accelerator, meaning it requires the presence of a primary accelerator for optimal performance. Butylcaptax is commonly used in the vulcanization of natural and synthetic rubbers, contributing to improved physical properties like tensile strength, elongation, and tear resistance. Its synthesis typically involves the reaction of 2-mercaptobenzothiazole with tert-butyl chloride. Research on butylcaptax focuses on optimizing its performance in different rubber formulations and exploring its potential applications in various industrial settings. Its importance lies in its ability to enhance the properties of rubber materials, enabling their use in diverse applications.'
butylcaptax: a herbicide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 16838 |
| SCHEMBL ID | 422527 |
| MeSH ID | M0066197 |
Synonyms (14)
| Synonym |
|---|
| butylcaptax |
| brn 0136982 |
| benzothiazole, 2-(butylthio)- |
| 2-butylthiobenzothiazole |
| 2-(butylthio)benzothiazole |
| 2-butylsulfanyl-1,3-benzothiazole |
| AKOS003653315 |
| 4-27-00-01838 (beilstein handbook reference) |
| 2314-17-2 |
| 2-(butylsulfanyl)-1,3-benzothiazole |
| SCHEMBL422527 |
| 2-n-butylmercapto-benzothiazole |
| DTXSID60177707 |
| 2-(butylthio)-1,3-benzothiazole |
Research
Studies (3)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.82
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.82 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.62 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |